Financial Performance - The company's operating revenue for Q1 2022 was CNY 201,478,102.51, representing a year-on-year increase of 3.45%[5] - The net profit attributable to shareholders decreased by 27.39% to CNY 22,758,304.16 compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses fell by 29.15% to CNY 21,142,559.91[5] - Basic and diluted earnings per share were both CNY 0.11, down by 26.67% year-on-year[6] - The weighted average return on equity decreased by 0.95 percentage points to 2.63%[6] - The company's net profit for Q1 2022 was CNY 22,758,304.16, a decrease of 27.5% compared to CNY 31,344,689.61 in Q1 2021[19] - Total revenue for Q1 2022 was CNY 25,150,801.64, down from CNY 37,554,425.96 in the same period last year, reflecting a decline of 33.0%[19] - Operating profit for Q1 2022 was CNY 25,125,462.49, compared to CNY 37,540,770.05 in Q1 2021, indicating a decrease of 33.1%[19] - The total comprehensive income for Q1 2022 was CNY 21,545,104.03, compared to CNY 23,771,266.04 in Q1 2021, reflecting a decrease of 9.4%[20] Cash Flow and Assets - The net cash flow from operating activities surged by 528.79% to CNY 16,842,120.30, primarily due to improved cash management and inventory reduction[10] - Cash flow from operating activities for Q1 2022 was CNY 16,842,120.30, significantly up from CNY 2,678,491.21 in Q1 2021, representing a growth of 529.5%[21] - The company reported cash inflows from operating activities totaling CNY 263,215,604.16, compared to CNY 168,253,758.13 in the previous year, an increase of 56.5%[21] - Cash and cash equivalents decreased to CNY 241,151,239.18 as of March 31, 2022, down from CNY 272,716,195.28 at the end of 2021[14] - Cash and cash equivalents at the end of Q1 2022 were CNY 217,586,094.57, down from CNY 265,487,386.42 at the end of Q1 2021, a decrease of 18.0%[21] - The company incurred a net cash outflow from investing activities of CNY 48,667,730.08 in Q1 2022, compared to CNY 22,662,203.40 in Q1 2021, indicating a worsening of 114.5%[21] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,256,605,486.45, a decrease of 2.27% from the end of the previous year[6] - Total assets decreased to CNY 1,256,605,486.45 from CNY 1,285,800,960.65 at the end of 2021[17] - Total liabilities decreased to CNY 380,126,129.17 from CNY 430,866,707.40 at the end of 2021[16] - The company's equity attributable to shareholders increased to CNY 876,479,357.28 from CNY 854,934,253.25 at the end of 2021[17] - Shareholders' equity attributable to the parent company increased by 2.52% to CNY 876,479,357.28[6] Expenses and Costs - Total operating costs for Q1 2022 were CNY 178,203,930.96, up 12.0% from CNY 158,972,341.27 in Q1 2021[18] - Gross profit for Q1 2022 was CNY 23,274,171.55, resulting in a gross margin of approximately 11.5%[18] - Research and development expenses for Q1 2022 were CNY 3,410,962.02, a decrease from CNY 4,060,726.60 in Q1 2021[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,976[12] - The company reported non-recurring gains of CNY 1,615,744.25, primarily from government subsidies and asset disposals[9] Foreign Exchange and Other Gains - The company reported a foreign exchange loss of CNY 1,669,497.70 in Q1 2022, compared to a loss of CNY 6,643,579.75 in Q1 2021, showing an improvement of 74.8%[21]
金海高科(603311) - 2022 Q1 - 季度财报